UKHSA_Scientific - Antibodies for Vaccine TaskForce
A Contract Award Notice
by UK HEALTH SECURITY AGENCY
- Source
- Contracts Finder
- Type
- Contract (Products)
- Duration
- 2 year
- Value
- £250K
- Sector
- HEALTH
- Published
- 12 Jan 2022
- Delivery
- 10 Jan 2022 to 10 Jan 2024
- Deadline
- 07 Jan 2022 12:00
Concepts
Location
1 buyer
- UK Health Security Agency London
1 supplier
- Stratech Scientific East Cambridgeshire
Description
UKHSA Awarded a contract for the supply of antibodies to Stratech Scientific Limited via Lot 1 of LAB4042 SU Framework. A polyclonal antibody is a critical component of a validated microneutralisation assay we have developed and implemented at Porton. The assay is used to test samples from SARS-CoV-2 clinical trials, to assess the potential of variants of concern to evade vaccines and to support pre-clinical work on the efficacy of developmental vaccines and therapeutics. The assay was developed using an antibody that was sourced from Stratech and to maintain the validated status of the assay we need to continue to have a supply of the same reagent. Any change to the reagent used required a significant amount of bridging work and potential revalidation (weeks to months) to demonstrate equivalence between the Stratech reagent and the potential replacement which is unlikely to be cost effective. For the reasons above, we awarded the contract to Stratech via Direct award under the Framework.
Award Detail
1 | Stratech Scientific (None)
|
CPV Codes
- 33696500 - Laboratory reagents
Indicators
- Contract is suitable for SMEs.
Other Information
Signed Stratech - SUPC Contract UKHSA_Redacted https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000H7N0/tJrLmaMNXQY...
Reference
- CF-0567300D0O000000rwimUAA1
- CF c3b5bcfa-199a-4d7f-991f-62a645833cd1